SCHEMBL2446293

SCHEMBL2446293

COc1cc(C=NO)cc(Cl)c1OC

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.75
CYP1A2 P05177 3/20 0.75
CYP3A4 P08684 3/20 0.75
CYP2C19 P33261 3/20 0.75
PKM P14618 1/20 0.75
HSD17B10 Q99714 2/20 0.69
HTT P42858 5/20 0.68
KMT2A Q03164 7/20 0.55
MEN1 O00255 6/20 0.55
MAPT P10636 5/20 0.55
HPGD P15428 4/20 0.55
LMNA P02545 3/20 0.51
CYP2D6 P10635 1/20 0.51
MAPK1 P28482 1/20 0.50
HSP90AA1 P07900 1/20 0.49
XBP1 P17861 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
POLB P06746 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.47
NPC1 O15118 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2446290 1.00 ALDH1A1 (0.75) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL3471744 0.87 HPGD (0.59) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL3471747 0.87 HPGD (0.59) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL15463039 0.87 HPGD (0.59) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL2446866 0.83 ALDH1A1 (0.61) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL2446863 0.83 ALDH1A1 (0.61) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL22824610 0.82 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL10050296 0.81 ALDH1A1 (0.52) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL30393930 0.81 ALDH1A1 (0.52) ALDH1A1CYP1A2CYP3A4CYP2C19PKM
SCHEMBL12120526 0.79 HSD17B10 (0.75) ALDH1A1CYP1A2CYP3A4CYP2C19PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 EP disclosed
CN-101316852-A Inhibitors of serine proteases VERTEX PHARMA (US) 2008-12-03 CN disclosed